Oxford Cannabinoid Technologies' deal for exclusive access to Canopy Growth's cannabinoid library

Article
Written By Rob Bennett

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, FRA:0CB) (LSE:OCTP, FRA:0CB) (OCT) chief executive, Dr John Lucas, talks to Proactive London's Katie Pilbeam about news of a licensing deal with Canopy Growth, one of the world’s largest cannabis companies.

As Lucas explains, under the deal they have exclusive access to Canopy’s entire cannabinoid derivative library. This includes 335 derivatives of cannabidiol (CBD), tetrahydrocannabinol (THC) and cannabigerol (CBG) and intellectual property rights, including 14 patent families and “associated product research and development”.

Rob Bennett https://www.oxcantech.com
Previous

Good shape, good budget and on track for Oxford Cannabinoid Technologies Holdings
Next

Oxford Cannabinoid Technologies says admission to the OTCQB is a logical next step